 |
 |
 |
 |
 |
 |
||
 |
 |
 |
 |
 |
| 3 | 1/1 | 返回列表 |
| 查看: 471 | 回復(fù): 2 | |||
lijizhi79木蟲(chóng) (小有名氣)
|
[交流]
GlaxoSmithKline and Novartis, starring players in a Big Pharma deal bonanza 已有2人參與
|
|
While the chattering classes were chattering about a potential Pfizer-AstraZeneca merger yesterday, three other drug giants were putting the finishing touches on a big announcement. Novartis ($NVS), whose strategic review has been making headlines for almost a year, agreed to swap some assets with GlaxoSmithKline ($GSK) and sell its animal health business to Eli Lilly ($LLY). Altogether, the transactions are worth more than $25 billion, a decent-sized figure in the scheme of pharma M&A. Even bigger? The changes these deals will wreak at the three companies, Novartis and GSK in particular. Glaxo will be out of the cancer business. Novartis will be out of vaccines and animal health. Together, the two companies will run a consumer health joint venture with a combined $11 billion or so in sales. And Eli Lilly will have an even heftier presence in animal health, where its Elanco unit already boasts major market share. We've taken a look at the different pieces of the three-way deal frenzy in Tuesday's news coverage. Follow the links to find out more. But here are the basics: Why did Glaxo choose to get out of the cancer business, and what does Novartis get for its $16 billion? CEOs Andrew Witty and Joe Jimenez have something to say about that. What does GSK propose to do with Novartis' vaccines business, particularly its meningitis B shot Bexsero? Build scale and add sales in a business that relies on high volumes--advantages worth up to $7.1 billion in up-front and milestone payments. How will Glaxo and Novartis meld their consumer health line-ups and save money in the process? In a joint venture controlled by GSK, with well-known brand names and distribution all over the world. What will Lilly gain in picking up Novartis' animal health business for $5.4 billion? Status as the second-biggest animal health company worldwide, plus a boost to this year's top line, for starters. We have one unanswered question, though. With rumors about Novartis' strategic review swirling for months, an asset swap with GSK never came up. How did these companies keep it quiet? -- Tracy Staton |
回復(fù)此樓» 猜你喜歡
計(jì)算化學(xué)與人工智能驅(qū)動(dòng)的MOFs性能預(yù)測(cè)與篩選技術(shù)
已經(jīng)有0人回復(fù)
-
研三實(shí)驗(yàn)求指導(dǎo)
已經(jīng)有0人回復(fù)
-
藥物學(xué)論文潤(rùn)色/翻譯怎么收費(fèi)?
已經(jīng)有226人回復(fù)
-
金屬材料多尺度計(jì)算模擬技術(shù)與應(yīng)用：微觀機(jī)理到宏觀性能的集成工作
已經(jīng)有0人回復(fù)
-
使用MolAICal進(jìn)行多肽虛擬篩選教程-同樣適用于蛋白質(zhì)和核酸的虛擬篩選
已經(jīng)有1人回復(fù)
-
使用MolAICal計(jì)算藥物化學(xué)過(guò)濾器MCFs及MCE-18描述符
已經(jīng)有0人回復(fù)
-
使用MolAICal發(fā)現(xiàn)蛋白受體潛在的活性口袋及位點(diǎn)
已經(jīng)有0人回復(fù)
-
華理藥學(xué)學(xué)碩求調(diào)劑，總分324
已經(jīng)有0人回復(fù)
-
江西科技師范大學(xué)微生物天然藥物老師介紹
已經(jīng)有23人回復(fù)
-
澳門理工大學(xué)人工智能藥物發(fā)現(xiàn)中心招收2026級(jí)博士研究生（申請(qǐng)-考核制）
已經(jīng)有10人回復(fù)
for5
木蟲(chóng) (正式寫(xiě)手)
- 應(yīng)助: 127 (高中生)
- 金幣: 3356.6
- 紅花: 10
- 帖子: 880
- 在線: 283.6小時(shí)
- 蟲(chóng)號(hào): 696070
- 注冊(cè): 2009-02-04
- 性別: GG
- 專業(yè): 微生物生理與生物化學(xué)
2樓2014-04-23 10:56:01
3樓2014-04-23 11:49:54
相關(guān)版塊跳轉(zhuǎn)
我要訂閱樓主 lijizhi79 的主題更新
| 3 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 294求調(diào)劑材料與化工專碩 +14 | 陌の森林 2026-03-18 | 14/700 |
|
|---|---|---|---|---|
|
|
[考研] 0817 化學(xué)工程 299分求調(diào)劑 有科研經(jīng)歷 有二區(qū)文章 +18 | rare12345 2026-03-18 | 18/900 |
|
|
[考博] 申博26年 +3 | 八6八68 2026-03-19 | 3/150 |
|
|
|
[考研] 085600材料與化工調(diào)劑 324分 +10 | llllkkkhh 2026-03-18 | 12/600 |
|
|
|
[考研] 0817調(diào)劑 +3 | 沒(méi)有答案_ 2026-03-14 | 3/150 |
|
|
|
[考研] 0703化學(xué) 305求調(diào)劑 +4 | FY_yy 2026-03-14 | 4/200 |
|
|
|
[考研] 0703化學(xué)調(diào)劑，求各位老師收留 +10 | 秋有木北 2026-03-14 | 10/500 |
|
|
|
[考研] 08工科 320總分 求調(diào)劑 +5 | 梨花珞晚風(fēng) 2026-03-17 | 5/250 |
|
|
|
[考博] 環(huán)境領(lǐng)域全國(guó)重點(diǎn)實(shí)驗(yàn)室招收博士1-2名 +3 | QGZDSYS 2026-03-13 | 5/250 |
|
|
|
[考研] 材料，紡織，生物（0856、0710），化學(xué)招生啦 +3 | Eember. 2026-03-17 | 9/450 |
|
|
|
[考研] 301求調(diào)劑 +4 | A_JiXing 2026-03-16 | 4/200 |
|
|
|
[考研] 材料專碩326求調(diào)劑 +6 | 墨煜姒莘 2026-03-15 | 7/350 |
|
|
|
[論文投稿] 有沒(méi)有大佬發(fā)小論文能帶我個(gè)二作 +3 | 增銳漏人 2026-03-17 | 4/200 |
|
|
|
[考研] 0703 物理化學(xué)調(diào)劑 +3 | 我可以上岸的對(duì)?/a> 2026-03-13 | 5/250 |
|
|
|
[考研] 327求調(diào)劑 +6 | 拾光任染 2026-03-15 | 11/550 |
|
|
|
[考研] 22408總分284求調(diào)劑 +3 | InAspic 2026-03-13 | 3/150 |
|
|
|
[考研] 中科大材料與化工319求調(diào)劑 +3 | 孟鑫材料 2026-03-14 | 3/150 |
|
|
|
[考研] 289求調(diào)劑 +4 | 這么名字咋樣 2026-03-14 | 6/300 |
|
|
|
[考研] 復(fù)試調(diào)劑 +3 | 呼呼？~+123456 2026-03-14 | 3/150 |
|
|
|
[考研] 304求調(diào)劑 +7 | 7712b 2026-03-13 | 7/350 |
|